Annual accounts
Total Exemption Full accounts
28/02/2027Filing deadline
- Next accounts made up to
- 31/05/2026
- Last accounts made up to
- 31/05/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Statement of capital following an allotment of shares on 2026-06-01
Total exemption full accounts made up to 2025-05-31
Confirmation statement made on 2025-09-28 with no updates
Total exemption full accounts made up to 2024-05-31
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
28/02/2027Filing deadline
Confirms the registry record is up to date
11/08/2027Filing deadline
The latest figures AKRO PHARMACEUTICAL COMPANY LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £367.62K
Total Assets
2024: £1.83M
Cash in Bank
2024: £172.17K
Total Liabilities
2024: £1.02M
Employees
2024: 5
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Total assets moved furthest, up 9.97% on 2024. See the full financial analysis for AKRO PHARMACEUTICAL COMPANY LIMITED.
The full financial record
Four ways through AKRO PHARMACEUTICAL COMPANY LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 6 | +1 |
| 2024 | 5 | 0 |
| 2023 | 5 | 0 |
| 2022 | 5 | 0 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 6 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 28/09/1998–Present | 0 | |
| Director | 28/09/1998–Present | 1 | |
| Nominee Director | 28/09/1998–28/09/1998 | 6002 | |
| Nominee Secretary | 28/09/1998–28/09/1998 | 4765 | |
| Secretary | 28/09/1998–Present | 0 | |
| Director | 01/06/2012–Present | 12 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 01/03/2017–Present | 2 | |
| 06/04/2016–01/03/2017 | 2 | |
| 01/03/2017–Present | 1 | |
| 06/04/2016–01/03/2017 | 1 | |
| 01/03/2017–30/01/2024 | 2 | |
| 06/04/2016–01/03/2017 | 0 | |
| 06/04/2016–01/03/2017 | 1 | |
| 01/03/2017–Present | 12 | |
| 01/03/2017–30/01/2024 | 1 |
Every document on the Companies House record, newest first.
Statement of capital following an allotment of shares on 2026-06-01
Total exemption full accounts made up to 2025-05-31
Confirmation statement made on 2025-09-28 with no updates
Total exemption full accounts made up to 2024-05-31
Confirmation statement made on 2024-09-28 with no updates
Notification of Samuel Tetteh Adjei as a person with significant control on 2017-03-01
Notification of Felicia Gloria Adjei as a person with significant control on 2017-03-01
Total exemption full accounts made up to 2023-05-31
Cessation of Samuel Tetteh Adjei as a person with significant control on 2024-01-30
Change of details for Mr Karl Adjei as a person with significant control on 2024-01-30
Cessation of Felicia Gloria Adjei as a person with significant control on 2024-01-30
Notification of Felicia Gloria Adjei as a person with significant control on 2017-03-01
Showing 12 of 82 filings
See when the next accounts and confirmation statement are due
1,377 UK companies are similar to AKRO PHARMACEUTICAL COMPANY LIMITED, sharing the same company status (Active), the same industry sector and activity group (Wholesale of pharmaceutical goods) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
3 Weekley Wood Close, Kettering, Northamptonshire NN14 1UQ
32 Willoughby Road, London, Greater London N8 0JG
Unit 2c Acre Park, Dalton Lane, Keighley, West Yorkshire BD21 4JH
Dane Mill Business Centre, Broadhurst Lane, Congleton, Cheshire CW12 1LA
22 St John Street, Newport Pagnell, Buckinghamshire MK16 8HJ
A short description of the company, written from its Companies House record.
AKRO PHARMACEUTICAL COMPANY LIMITED is a private limited company registered in the United Kingdom, based in Abacus House, 68a North Street, Romford, Essex RM1 1DA. Companies House classifies its business as Wholesale of pharmaceutical goods. It has been on the register for 28 years.
The register currently records it as active. Its 2025 accounts report net assets of £399.22K and 6 employees.
Answered from this company's own registry record and filed figures.
Companies House records AKRO PHARMACEUTICAL COMPANY LIMITED under one registered business activity: Wholesale of pharmaceutical goods (46.46 - SIC 2007).
AKRO PHARMACEUTICAL COMPANY LIMITED is recorded as active on the Companies House register, and has been on it since 28/09/1998.
The most recent accounts Okredo holds cover 2025 and report net assets of £399.22K, total assets of £2.01M, cash in bank of £145.96K and total liabilities of £1.19M.
The most recent document on the record is dated 15/07/2026: Statement of capital following an allotment of shares on 2026-06-01, 2 months ago.
On the current registry record, accounts are due by 28/02/2027 and the next confirmation statement is due by 11/08/2027.
Companies House lists 6 officers (4 currently in post) and 9 people with significant control (3 current).